文献速递心力衰竭与心肌病冠心病

急性心肌梗死合并心源性休克患者轻度治疗性低温的随机对照试验

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction.
PubMed 文献 · Circulation · 2019-01-01

本研究为随机对照试验,纳入40例急性心肌梗死合并心源性休克接受直接PCI的患者,1:1随机分为轻度治疗性低温24小时组或对照组。主要终点24小时心脏功率指数无显著差异(0.41 vs 0.36 W/m²,P=0.50)。低温组动脉乳酸在6、8、10小时显著更高且下降更慢,30天死亡率无差异(60% vs 50%)。

要点

  • 轻度治疗性低温未改善急性心梗合并心源性休克患者24小时心脏功率指数。
  • 低温组动脉乳酸在6、8、10小时显著更高且下降更慢(交互P=0.03)。
  • 30天死亡率两组无差异(60% vs 50%,HR 1.27,95%CI 0.55-2.94,P=0.55)。

核心结论

  • 在急性心肌梗死合并心源性休克患者中,轻度治疗性低温未能对24小时心脏功率指数显示出实质性有益效应。

研究设计与样本

  • 随机对照试验,纳入40例急性心肌梗死合并心源性休克接受直接PCI且无轻度治疗性低温经典适应证的患者,1:1随机分为轻度治疗性低温24小时组或对照组。

主要发现

  • 24小时心脏功率指数低温组与对照组无相关差异:0.41(四分位距0.31-0.52)vs 0.36(四分位距0.31-0.48)W/m²,P=0.50;中位差-0.025 W/m²,95%CI -0.12至0.06。
  • 所有其他血流动力学测量均无统计学差异。
  • 低温组动脉乳酸在6、8、10小时显著更高且下降更慢(交互P=0.03)。
  • 30天死亡率无差异:60% vs 50%;风险比1.27;95%CI 0.55-2.94;P=0.55。

临床怎么用

  • 对于急性心肌梗死合并心源性休克接受直接PCI且无经典低温适应证的患者,轻度治疗性低温未能改善24小时心脏功率指数,且与乳酸清除延迟相关,不支持常规应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Experimental trials suggest improved outcome by mild therapeutic hypothermia for cardiogenic shock after acute myocardial infarction. The objective of this study was to investigate the hemodynamic effects of mild therapeutic hypothermia in patients with cardiogenic shock complicating acute myocardial infarction. METHODS: Patients (n=40) with cardiogenic shock undergoing primary percutaneous coronary intervention without classic indications for mild therapeutic hypothermia underwent randomization in a 1:1 fashion to mild therapeutic hypothermia for 24 hours or control. The primary end point was cardiac power index at 24 hours; secondary end points included other hemodynamic parameters and serial measurements of arterial lactate. RESULTS: No relevant differences were observed for the primary end point of cardiac power index at 24 hours (mild therapeutic hypothermia versus control: 0.41 [interquartile range, 0.31-0.52] versus 0.36 [interquartile range, 0.31-0.48] W/m2; P=0.50; median difference, -0.025 W/m2; 95% CI, -0.12 to 0.06). Similarly, all other hemodynamic measurements were not statistically different. Arterial lactate levels at 6, 8, and 10 hours were significantly higher in patients in the mild therapeutic hypothermia group with a slower decline ( P for interaction=0.03). There were no differences in 30-day mortality (60% versus 50%; hazard ratio, 1.27; 95% CI, 0.55-2.94; P=0.55). CONCLUSIONS: In this randomized trial, mild therapeutic hypothermia failed to show a substantial beneficial effect on cardiac power index at 24 hours in patients with cardiogenic shock after acute myocardial infarction. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01890317.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Fuernau G, Beck J, Desch S, et al. Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction. Circulation. 2019. PMID: 30026282. doi:10.1161/CIRCULATIONAHA.117.032722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。